| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.097 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |